FDA Approves First Medication to Treat Severe Frostbite
J&J unit to pay $360 million to U.S. to resolve charity kickback probe
Japan's Pharmaceutical Affairs and Food Sanitation Council's First Committee will review Takeda Pharmaceutical's glatiramer acetate drug approval application for relapsing multiple sclerosis on Aug. 28, a Ministry of Health, Labor and Welfare (MHLW) spokesman said.